Showing results (201-210 of 432) with videos related to

Sort By:
Pageof 44
JAMA Oncology|November 5, 2020
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing InterferenceKendal Jensen, Eric Q Konnick, Michael T Schweizer, et al.
Clinical & Experimental Metastasis|November 1, 2007
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastasesColm Morrissey, Lawrence D True, Martine P Roudier, et al.
Molecular Cancer Research : MCR|February 12, 2024
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
FEBS Open Bio|May 23, 2025
Identifying prognostic targets in metastatic prostate cancer beyond AREmily Feng, Eric Feng, Tracy Berg, et al.
The Prostate|October 30, 2009
The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cellsColm Morrissey, Janice S Lai, Lisha G Brown, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2024
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617Ridvan Arda Demirci, Roman Gulati, Jessica E Hawley, et al.
The Journal of Clinical Investigation|February 15, 2021
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKTTao Shen, Wei Wang, Wolong Zhou, et al.
Plos One|June 2, 2018
A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
The Journal of Clinical Investigation|July 21, 2010
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variantShihua Sun, Cynthia C T Sprenger, Robert L Vessella, et al.
Plos One|August 16, 2018
Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancerMichael T Schweizer, Kathleen Haugk, Jožefa S McKiernan, et al.
Pageof 44